237690 — ST Pharm Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Annual cashflow statement for ST Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-13,155	3,377	17,516	17,523	32,464
Depreciation
Amortisation
Non-Cash Items	-1,055	10,100	15,604	27,646	19,656
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital	-20,793	-20,622	-43,689	-66,898	31,750
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-20,935	7,270	7,031	1,298	109,451
Capital Expenditures	-17,444	-51,918	-60,663	-43,443	-83,224
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-51,630	43,885	54,939	-38,945	-3,318
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-69,074	-8,034	-5,724	-82,388	-86,543
Financing Cash Flow Items	-1,486	-245	462	122	-627
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	115,927	-116	10,808	81,401	-10,954
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	25,802	578	10,998	-104	13,308